Non-self-sufficiency as a primary outcome measure in ALS trials-Reference-Cited by-同舟云学术

Non-self-sufficiency as a primary outcome measure in ALS trials

Published:2015-10-16 Issue:1-2 Volume:17 Page:77-84
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Marin Benoît,Bianchi Elisa,Pupillo Elisabetta,Lunetta Christian,Tremolizzo Lucio,Logroscino Giancarlo,Chiò Adriano,Preux Pierre Marie,Beghi Ettore

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology

Link

http://www.tandfonline.com/doi/pdf/10.3109/21678421.2015.1074704

Reference18 articles.

1. The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials

2. European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis (ALS). 2014 [cited 2014 July 17th]; Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147005.pdf.

3. The Amyotrophic Lateral Sclerosis Functional Rating Scale

4. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function

5. Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medium-Chain Fatty Acids Rescue Motor Function and Neuromuscular Junction Degeneration in a Drosophila Model of Amyotrophic Lateral Sclerosis;Cells;2023-08-28

2. Retrospective observational study on the use of acetyl-l-carnitine in ALS;Journal of Neurology;2023-06-28

3. Longitudinal Timed Up and Go Assessment in Amyotrophic Lateral Sclerosis: A Pilot Study;European Neurology;2021

4. The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis;Scientific Reports;2020-09-23

5. ALSUntangled 53: Carnitine supplements;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2020-02-11